Galectin-8 ameliorates murine autoimmune ocular pathology and promotes a regulatory T cell response

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Sampson, James F ^a   Hasegawa, Eiichi ^b   Mulki, Lama ^b   Suryawanshi, Amol ^c   Jiang, Shuhong ^d,e   Chen, Wei Sheng ^a   Rabinovich, Gabriel A ^f   Connor, Kip M ^b   Panjwani, Noorjahan ^a,c,e  

^a TUFTS UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY   (United States)

^e People's Hospital of Inner Mongolia   (China)

^f Cell Molecular and Developmental Biology Sackler School of Graduate Biomedical Sciences Tufts University ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GALECTIN 8; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; NEUROPILIN 1; ALPHA E INTEGRINS; ALPHA INTEGRIN; CTLA4 PROTEIN, MOUSE; GALECTIN; GALECTIN-8, MOUSE; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE UVEITIS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE UVEITIS; EXPERIMENTAL UVEITIS; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOREGULATION; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MOUSE; MURINE MODEL; NONHUMAN; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; REGULATORY T LYMPHOCYTE; RETINA; SPLEEN; TH1 CELL; TH17 CELL; ANIMAL; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; UVEITIS;

ANIMALIA; MURINAE; MUS;

ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CTLA-4 ANTIGEN; DISEASE MODELS, ANIMAL; GALECTINS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTEGRIN ALPHA CHAINS; INTERLEUKIN-10; LYMPH NODES; MICE; NEUROPILIN-1; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; UVEITIS;

EID: 84938692342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130772     Document Type: Article

References (48)

1. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br. J. Ophthalmol. 1996; 80:844-8. PMID: 8962842
2. Ilhan F, Demir T, Türkçüoʇlu P, Turgut B, Demir N, Gödekmerdan A. Th1 polarization of the immune response in uveitis in Behçet's disease. Can. J. Ophthalmol. 2008; 43:105-8. doi: 10.3129/i07-179 PMID: 18204495
3. Amadi-Obi A, Yu C-R, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 2007; 13:711-8. doi: 10.1038/nm1585 PMID: 17496900
4. Ruggieri S, Frassanito MA, Dammacco R, Guerriero S. Treg lymphocytes in autoimmune uveitis. Ocul. Immunol. Inflamm. 2012; 20:255-61. doi: 10.3109/09273948.2012.681830 PMID: 22564107
5. Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, et al. Blockade of interleukin-6 signaling suppresses not only Th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 2011; 52:3264-71. doi: 10.1167/iovs.10-6272 PMID: 21330657
6. Grajewski RS, Silver PB, Agarwal RK, Su S-B, Chan C-C, Liou GI, et al. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J. Exp. Med. 2006; 203:851-6. doi: 10.1084/jem.20050429 PMID: 16585264
7. Toscano MA, Commodaro AG, Ilarregui JM, Bianco GA, Liberman A, Serra HM, et al. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 2006; 176:6323-32. PMID: 16670344
8. Josefowicz SZ, Lu L-F, Rudensky AY. Regulatory T Cells: Mechanisms of Differentiation and Function. Annu. Rev. Immunol. 2012; 30:531-564. doi: 10.1146/annurev.immunol.25.022106.141623 PMID: 22224781
9. Garín MI, Chu C-C, Golshayan D, Cernuda-Morollón E, Wait R, Lechler RI. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood. 2007; 109:2058-65. doi: 10.1182/blood-2006-04-016451
10. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007; 13:1450-7. doi: 10.1038/nm1680 PMID: 18026113
11. Dalotto-Moreno T, Croci DO, Cerliani JP, Martinez-Allo VC, Dergan-Dylon S, Méndez-Huergo SP, et al. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents meta-static disease. Cancer Res. 2013; 73:1107-17. doi: 10.1158/0008-5472.CAN-12-2418 PMID: 23204230
12. Seki M, Oomizu S, Sakata K-M, Sakata A, Arikawa T, Watanabe K, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008; 127:78-88. doi: 10.1016/j.clim.2008.01.006 PMID: 18282810
13. Wu C, Thalhamer T, Franca RF, Xiao S, Wang C, Hotta C, et al. Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells. Immunity. 2014; 41:270-282. doi: 10.1016/j.immuni.2014.06.011 PMID: 25065622
14. Rabinovich GA, Toscano MA. Turning "sweet" on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009; 9:338-52. doi: 10.1038/nri2536 PMID: 19365409
15. Quattroni P, Li Y, Lucchesi D, Lucas S, Hood DW, Herrmann M, et al. Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells. Cell. Microbiol. 2012; 14:1657-75. doi: 10.1111/j.1462-5822.2012.01838.x PMID: 22827322
16. Markowska AI, Liu F-T, Panjwani N. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J. Exp. Med. 2010; 207:1981-93. doi: 10.1084/jem.20090121 PMID: 20713592
17. Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2006; 103:5060-5. doi: 10.1073/pnas.0511167103 PMID: 16549783
18. Oomizu S, Arikawa T, Niki T, Kadowaki T, Ueno M, Nishi N, et al. Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. Clin. Immunol. 2012; 143:51-8. doi: 10.1016/j.clim.2012.01.004 PMID: 22341088
19. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007; 8:825-34. doi: 10.1038/ni1482 PMID: 17589510
20. Fermino ML, Dias FC, Lopes CD, Souza MA, Cruz ÂK, Liu F-T, et al. Galectin-3 negatively regulates the frequency and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells and influences the course of Leishmania major infection. Eur. J. Immunol. 2013; 43:1806-17. doi: 10.1002/eji.201343381 PMID: 23592449
21. Cedeno-Laurent F, Opperman M, Barthel SR, Kuchroo VK, Dimitroff CJ. Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J. Immunol. 2012; 188:3127-37. doi: 10.4049/jimmunol.1103433 PMID: 22345665
22. Ideo H, Seko A, Ishizuka I, Yamashita K. The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology. 2003; 13:713-23. doi: 10.1093/glycob/cwg094 PMID: 12851289
23. Mattapallil MJ, Wawrousek EF, Chan C-C, Zhao H, Roychoudhury J, Ferguson TA, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest. Ophthalmol. Vis. Sci. 2012; 53:2921-7. doi: 10.1167/iovs.12-9662 PMID: 22447858
24. Diskin S, Chen W-S, Cao Z, Gyawali S, Gong H, Soza A, et al. Galectin-8 promotes cytoskeletal rear-rangement in trabecular meshwork cells through activation of Rho signaling. PLoS One. 2012; 7: e44400. doi: 10.1371/journal.pone.0044400 PMID: 22973445
25. Avichezer D, Grajewski RS, Chan C-C, Mattapallil MJ, Silver PB, Raber JA, et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J. Exp. Med. 2003; 198:1665-76. doi: 10.1084/jem.20030413 PMID: 14657219
26. Xu H, Koch P, Chen M, Lau A, Reid DM, Forrester JV. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp. Eye Res. 2008; 87:319-26. doi: 10.1016/j.exer.2008.06.012 PMID: 18634784
27. Lee DJ, Biros DJ, Taylor AW. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis. Int. Immunopharmacol. 2009; 9:1079-1086. doi: 10.1016/j.intimp.2009.05.001 PMID: 19426838
28. Caspi RR, Roberge FG, Chan C, Wiggert B, Gerald J, Rozenszajn LA, et al. Experimental Autoimmune Uveoretinitis Induced in Mice with Two Different Retinal Antigens. J. Immunol. 1988; 140:1490-1495. PMID: 3346541
29. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008; 205:799-810. doi: 10.1084/jem.20071258 PMID: 18391061
30. Suffia I, Reckling SK, Salay G, Belkaid Y. A Role for CD103 in the Retention of CD4+ CD25+ Treg and Control of Leishmania major Infection. J. Immunol. 2005; 174:5444-5455. PMID: 15845457
31. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 2012; 209:1713-22, S1-19. doi: 10.1084/jem.20120822 PMID: 22966003
32. Sun B, Rizzo LV, Sun S, Chan C, Wiggert B, Wilder RL, et al. Genetic Susceptibility to Experimental Autoimmune Uveitis Involves More than a Predisposition to Generate a T Helper-1-Like or a T Helper-2-Like Response. J. Immunol. 1997; 159:1004-1011. PMID: 9218623
33. Li G, Yuan L, Ren X, Nian H, Zhang L, Han ZC, et al. The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis. Clin. Exp. Immunol. 2013; 173:28-37. doi: 10.1111/cei.12080 PMID: 23607419
34. Yin H, Vistica BP, Chan C-C, Strominger JL, Gery I. Inhibition of experimental autoimmune uveitis by amino acid copolymers. J. Neuroimmunol. 2009; 215:43-8. doi: 10.1016/j.jneuroim.2009.08.002 PMID: 19748134
35. Sun B, Sun SH, Chan CC, Caspi RR. Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance? Exp. Eye Res. 2000; 70:493-502. doi: 10.1006/exer.1999.0808 PMID: 10865998
36. Rizzo LV, Xu H, Chan CC, Wiggert B, Caspi RR. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int. Immunol. 1998; 10:807-14. PMID: 9678762
37. Massardo L, Metz C, Pardo E, Mezzano V, Babul M, Jarpa E, et al. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus. 2009; 18:539-46. doi: 10.1177/0961203308099973 PMID: 19395456
38. Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, et al. Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology. 2003; 13:755-63. doi: 10.1093/glycob/cwg102 PMID: 12881409
39. Tsai C-M, Guan C-H, Hsieh H-W, Hsu T-L, Tu Z, Wu K-J, et al. Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation. J. Immunol. 2011; 187:1643-52. doi: 10.4049/jimmunol.1100297 PMID: 21753146
40. Tribulatti MV, Mucci J, Cattaneo V, Agüero F, Gilmartin T, Head SR, et al. Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation. Glycobiology. 2007; 17:1404-12. doi: 10.1093/glycob/cwm104 PMID: 17893094
41. Jiang H-R, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, et al. Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis. J. Immunol. 2009; 182: 1167-1173. doi: 10.4049/jimmunol.182.2.1167 PMID: 19124760
42. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta. 2002; 1572:232-54. PMID: 12223272
43. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, Leffler H, et al. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 2008; 283:10109-23. doi: 10.1074/jbc.M709545200 PMID: 18216021
44. Zhuo Y, Chammas R, Bellis SL. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J. Biol. Chem. 2008; 283:22177-85. doi: 10.1074/jbc.M8000015200 PMID: 18676377
45. Ideo H, Matsuzaka T, Nonaka T, Seko A, Yamashita K. Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans. J. Biol. Chem. 2011; 286:11346-55. doi: 10.1074/jbc.M110.195925 PMID: 21288902
46. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein M. Immune Modulatory Treatment of Trinitrobenzene Sulfonic Acid Colitis with Calcitriol Is Associated with a Change of a T Helper (Th) 1 / Th17 to a Th2 and Regulatory T Cell Profile. J. Phamacology Exp. Ther. 2008; 324:23-33. doi: 10.1124/jpet.107.127209.the PMID: 17911375
47. Gao Q, Jiang Y, Ma T, Zhu F, Gao F, Zhang P, et al. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J. Immunol. 2010; 185:5820-7. doi: 10.4049/jimmunol.1000116 PMID: 20952673
48. Winthrop KL. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat. Clin. Pract. Rheumatol. 2006; 2:602-10. doi: 10.1038/ncprheum0336 PMID: 17075599